Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.05% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 23.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 14.16% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 30.41% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.52% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | 0.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19% |
| Dec 31, 2025 | 12.40% |
| Sep 30, 2025 | 23.20% |
| Jun 30, 2025 | 18.69% |
| Mar 31, 2025 | 25.46% |
| Dec 31, 2024 | 9.33% |
| Sep 30, 2024 | 20.96% |
| Jun 30, 2024 | 10.72% |
| Mar 31, 2024 | 28.80% |
| Dec 31, 2023 | 9.43% |
| Sep 30, 2023 | 21.12% |
| Jun 30, 2023 | 2.85% |
| Mar 31, 2023 | -6.28% |
| Dec 31, 2022 | -18.97% |
| Sep 30, 2022 | -36.19% |
| Jun 30, 2022 | -63.08% |
| Mar 31, 2022 | -30.19% |
| Dec 31, 2021 | -44.86% |
| Sep 30, 2021 | -65.89% |
| Jun 30, 2021 | -29.69% |